Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Finance

Results: 433-444 of 42358

PR Newswire associated0

Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)

PR Newswire associated0

MGI Tech Secures Three iF Design Awards for Breakthrough in Sequencing and Ultrasound

Business Wire associated0

Barilla Opens Global Call for Startups Through Good Food Makers 2026

ZOE Energy Storage Partners with Local Saudi Ally to Build Kingdom's First World-Class Battery Storage Manufacturing Base

Ericsson to relocate Stockholm operations to Hagastaden

BioArctic's partner Eisai presents sales simulation of potential future sales of Leqembi® at its Investor Relations Day

PR Newswire associated0

BIRKENSTOCK LEAVES ITS FOOTPRINT IN BOLOGNA

PR Newswire associated0

isinwheel Rolls Out 8th Anniversary Campaign in Europe with Special Offers on Electric Scooters

PR Newswire associated0

XCMG Chairman Yang Dongsheng Joins Xuzhou Delegation on Economic and Trade Visits to Indonesia and Australia

PR Newswire associated0

GCL SI and Getz Energy Sign MOU for 1 GW of Advanced PV Modules to Support Thailand's Clean Energy Transition

Business Wire logo

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease

CGTN: Putting people first: A guiding principle in China's governance

  • Prev Page
  • 1
  • 2
  • …
  • 36
  • 37
  • 38
  • …
  • 3529
  • 3530
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us